Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Prostate Cancer Stem Cells: New Hope for Therapy?

The critical tumour-initiating cells that support the growth of prostate cancer the second most common cause of cancer-related death in the male population can now be analysed and propagated at an unprecedented level. Steve Holmes at Pro-Cure Therapeutics Ltd gives an insight into the new methodologies being employed.

Steve Holmes (September 2011)

Keywords: The critical tumour-initiating cells that support the growth of prostate cancer the second most common cause of cancer-related death in the male population can now be analysed and propagated at an unprecedented level. Steve Holmes at Pro-Cure Therapeutics Ltd gives an insight into the new methodologies being employed.

    View full article    |    Back to Discovery Technology section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |